Teva Respiratory, the U.S.-based respiratory subsidiary of Israeli Teva Pharmaceutical Industries announced that the FDA has approved its quick relief inhaler ProAir HFA with a dose counter, for the treatment or prevention of breathing disorders in patients four years of age and older. The dose counter is designed to help patients suffering drom disorders such […]